Lipase maturation factor 1: Its expression in Zucker diabetic rats, and effects of metformin and fenofibrate
Authors:
- A. BassetABA. Basset
- P. Del CarminePCP. Del Carmine
- M. BeylotMBM. Beylot
- 31 December 2009
- journal article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 35 (6) , 452-457
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemiaNature Genetics, 2007
- Sorting out the roles of PPAR in energy metabolism and vascular homeostasisJournal of Clinical Investigation, 2006
- AMP-activated Protein Kinase Is Required for the Lipid-lowering Effect of Metformin in Insulin-resistant Human HepG2 CellsJournal of Biological Chemistry, 2004
- Mechanisms of the Triglyceride- and Cholesterol-Lowering Effect of Fenofibrate in Hyperlipidemic Type 2 Diabetic PatientsDiabetes, 2002
- Maturation of Lipoprotein Lipase in the Endoplasmic ReticulumJournal of Biological Chemistry, 2002
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic stateMetabolism, 2000
- Expression of Putative Fatty Acid Transporter Genes Are Regulated by Peroxisome Proliferator-activated Receptor α and γ Activators in a Tissue- and Inducer-specific MannerJournal of Biological Chemistry, 1998
- Regulation of the synthesis, processing and translocation of lipoprotein lipaseBiochemical Journal, 1992
- Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjectsEuropean Journal of Clinical Pharmacology, 1983